Evidence map›Paper›PMID 22373641›Full record

ReviewSeminars in cell & developmental biology2012

Notch and disease: a growing field.

Angeliki Louvi, Spyros Artavanis-Tsakonas

Abstract readReview
In one paragraph

Review in Seminars in cell & developmental biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 114 papers.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 191 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Molecular insights and clinical implications for the tumor suppressor role of SCFBiochimica et biophysica acta. Reviews on cancer · 2024
    Review
  6. Review
  7. Review
  8. Article
  9. Structural features of the Notch ankyrin domain-Deltex WWEStructure (London, England : 1993) · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Angeliki LouviDepartment of Neurosurgery and Neurobiology, Program on Neurogenetics, Yale School of Medicine, New Haven, CT, United States. angeliki.louvi@yale.edu
Spyros Artavanis-Tsakonas
Harvard University · USYale University · US

Funding

Notch Signaling in Mammary Development and TumorigenesisR01CA098402 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI ARTAVANIS-TSAKONAS, SPYRIDON · 2003 to 2013
$3.6M
NCI NIH HHS R01 CA098402
6 · The paper itself

Abstract

Signals through the Notch receptors are used throughout development to control cellular fate choices. Our intention here is to provide an overview of the involvement of Notch signaling in human disease, which, keeping pace with the known biology of the pathway, manifests itself in a pleiotropic fashion. A pathway with such broad action in normal development, a profound involvement in the biology of adult stem cells and intricate and complex controls governing its activity, poses numerous challenges. We provide an overview of Notch related pathologies identified thus far and emphasize aspects that have been modeled in experimental systems in order to understand the underlying pathobiology and, hopefully, help the definition of rational therapeutic avenues.

Indexed as

MutationAlagille SyndromeAnimalsBone Diseases, MetabolicCADASILCardiovascular DiseasesGenetic PleiotropyHumansNeoplasmsOncogenesReceptors, NotchSignal TransductionReceptors, Notch

Identifiers

PMID22373641
PMCPMC4369912
OpenAlexW2036540072

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.